Efficacy of Ombitasvir/Paritaprevir/ and Dasabuvir plus /-Ribavirin in Patients Receiving Concomitant Acid-Reducing Agents in Phase 3 Trials
2015
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI